Key Takeaways IQV gained 25.5% in three months, outpacing the industry's 12.1% rise.IQV named AWS its Preferred Agentic Cloud Provider to accelerate clinical trial automation and analytics.IQV's R&DS backlog hit $32.4B, with $8.1B converting to revenues over the next 12 months.IQVIA Holdings, Inc. (IQV) has gained 25.5% over the past three months compared with the industry’s 12.1% rise.The company has an expected long-term EPS (three to five years) growth rate of 8.38%. Earnings are expected to register yea ...